Losar-hctz 50-12.5 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FHYQ0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,305
Award facts
- Contract value 100% obligated
- $1,305.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order valued at $1,305.36 to DMS Pharmaceutical Group Inc. for LOSAR-HCTZ 50-12.5 tablets (a combination antihypertensive medication) with an ultimate completion date of December 29, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. This delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group holds a single-award IDC under the PPV-G GEN V program with a ceiling value of $499,999,999 and a performance period extending through December 31, 2036. The company has demonstrated substantial federal contracting activity supplying a comprehensive range of pharmaceuticals including branded and generic prescription medications, biologics, vaccines, and specialty products to support recurring medical supply needs across military healthcare operations globally. The current delivery order represents a routine pharmaceutical supply transaction consistent with DMS Pharmaceutical Group's established role as a critical supplier within the Defense Logistics Agency's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FHYQ0?
SPE2DR26FHYQ0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FHYQ0 worth?
The government has obligated $1,305 on SPE2DR26FHYQ0.
Is contract SPE2DR26FHYQ0 an order under another contract?
Yes. SPE2DR26FHYQ0 is a delivery order under SPE2DR25D9762, an indefinite delivery contract.
Was contract SPE2DR26FHYQ0 competed?
The extent of competition for SPE2DR26FHYQ0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award